/Companies

NxGenPort

2 known investors

Find your way into NxGenPort

Sign up to see every warm intro you have to NxGenPort

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the NxGenPort team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

NXgenPort is developing a smart implantable chemotherapy port that integrates optical sensing and machine learning to monitor blood cell dynamics and other physiological changes in vivo, paired with a digital health platform for data analysis. It targets oncology care teams and cancer patients, aiming to detect treatment complications like infection and neutropenia early for remote patient monitoring.

Founders & leadership

CSCathy Skinner
Cathy SkinnerCo-founder/Co-inventor & Chief Executive Officer
RWRosanne Welcher
Rosanne WelcherCo-founder/Co-inventor & Chief Operating OfficerShe brings expertise in companion diagnostics, in vitro diagnostics development, regulatory affairs, and oncology.

Investors · 2

Frequently asked questions

What does NxGenPort do?
NXgenPort is developing a smart implantable chemotherapy port that integrates optical sensing and machine learning to monitor blood cell dynamics and other physiological changes in vivo, paired with a digital health platform for data analysis. It targets oncology care teams and cancer patients, aiming to detect treatment complications like infection and neutropenia early for remote patient monitoring.
Who founded NxGenPort?
NxGenPort was founded by Cathy Skinner, Rosanne Welcher.
Who are NxGenPort's investors?
NxGenPort's investors include Cancer Fund, GROOVE CAPITAL.